Sanofi Sponsored Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sanofi Sponsored Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sanofi Sponsored Phase Today - Breaking & Trending Today

$First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma | Business - Vimarsana News$

First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma | Business

Published: July 11, 2023

MARSEILLE, France--(BUSINESS WIRE)--Jul 11, 2023--

Source: maryvilleforum.com

$First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma | Nation/World - Vimarsana News$

First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma | Nation/World

Published: July 11, 2023

MARSEILLE, France--(BUSINESS WIRE)--Jul 11, 2023--

Source: bdtonline.com

$Innate Pharma SA Announces First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma - Vimarsana News$

Innate Pharma SA Announces First Patient Dosed in SAR'514 / IPH6401 Phase 1/2 Clinical Trial in Relapsed/Refractory Multiple Myeloma

Published: July 11, 2023

Innate Pharma SA announced that the first patient was dosed in a Sanofi-sponsored Phase 1/2 clinical trial , evaluating SAR'514 /IPH6401 in relapsed/refractory Multiple Myeloma and...

Source: marketscreener.com